申请人:University of Utah Research Foundation
公开号:US11339173B2
公开(公告)日:2022-05-24
The present disclosure is concerned with benzimidazole compounds and methods of using these compounds for the treatment of hepatitis (e.g., hepatitis C), RNA virus infections (e.g., Zika virus, dengue virus, Powassan virus, Chikungunya virus, Enterovirus, respiratory syntactical virus (RSV), Rift Valley fever, Influenza virus, Tacaribe virus, Mayaro virus, West Nile virus, yellow fever virus, and coronavirus), and disorders of uncontrolled cellular proliferation (e.g., cancer). This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
本公开涉及苯并咪唑化合物以及使用这些化合物治疗肝炎(如丙型肝炎)、RNA 病毒感染(如、寨卡病毒、登革热病毒、Powassan 病毒、基孔肯雅病毒、肠道病毒、呼吸道综合病毒 (RSV)、裂谷热、流感病毒、Tacaribe 病毒、Mayaro 病毒、西尼罗河病毒、黄热病病毒和冠状病毒),以及细胞增殖失控疾病(如癌症)。本摘要旨在作为在特定技术领域进行搜索的扫描工具,并非对本发明的限制。